Taysha Gene Therapies récupère l'intégralité des droits sur son programme phare TSHA-102 en évaluation clinique pour le traitement du syndrome de Rett
Taysha Gene Therapies récupère l'intégralité des droits sur son programme phare TSHA-102 en évaluation clinique pour le traitement du syndrome de Rett
6 months ago
zonebourse.com
Scientists see foam as starting point of a path to bedside gene therapy
Scientists see foam as starting point of a path to bedside gene therapy
5 months ago
fredhutch.org
Taysha : la thérapie génique AAV9 pour le syndrome de Rett obtient la désignation « Breakthrough Therapy » de la FDA
Taysha : la thérapie génique AAV9 pour le syndrome de Rett obtient la désignation « Breakthrough Therapy » de la FDA
6 months ago
zonebourse.com
Taysha Gene Therapies Announces CEO Changes
Taysha Gene Therapies Announces CEO Changes
Dec 16, 2022
marketscreener.com
Taysha Gene Therapies Commences Offering of Common Stock, Warrants
Taysha Gene Therapies Commences Offering of Common Stock, Warrants
11 months ago
marketscreener.com
Taysha Gene Therapies | LinkedIn
Taysha Gene Therapies | LinkedIn
10 months ago
linkedin.com
R.A. Session II, Taysha Gene Therapies | KERA
R.A. Session II, Taysha Gene Therapies | KERA
Nov 13, 2020
kera.org
Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adolescent ...
11 months ago
finanznachrichten.de
Taysha Gene Therapies, Inc. Rings the Nasdaq Stock Market Closing Bell
Oct 4, 2021
nasdaq.com
Gene Therapy: An Overview of Advances and Applications of Gene Therapies | Harvard Medical School Professional, Corporate, and Continuing Education
10 months ago
harvard.edu
Preliminary Results from Gene Therapy in Tay-Sachs Disease Patients
Mar 31, 2022
checkrare.com
24:14
Taysha has released a video update about their gene replacement clinical trial for Rett syndrome — the REVEAL Adult Study. Taysha's Rett program, TSHA-102, is the first gene therapy clinical trial for Rett and got its start through RSRT's Gene Therapy Consortium and MECP2 Consortium. | Rett Syndrome Research Trust
1.7K viewsNov 17, 2022
FacebookRett Syndrome Research Trust
First gene therapy for Tay-Sachs disease successfully given to two children
Feb 14, 2022
umassmed.edu
The Blogs: Our Tay-Sachs gene therapy was successfully given to 2 children
Feb 15, 2022
timesofisrael.com
The future of gene therapy has arrived, and it's changing lives
Apr 18, 2024
osu.edu
First Gene Therapy for Tay-Sachs Disease Successfully Given to Two Children
Feb 15, 2022
scientificamerican.com
0:47
FDA approves Novartis gene therapy for rare genetic disorder
May 24, 2019
CNBCBerkeley Lovelace Jr.,Angelica Peebles
A promising genetic treatment tailor-made for a baby born with a rare disorder
11 months ago
npr.org
6:32
Therapeutic Strategies For Tay-Sachs Disease
12 views1 month ago
YouTubeEducational courses
1:39
Ottawa girl denied gene therapy trial for being one year too old
4.1K views1 week ago
YouTubeCTV News
4:43
Taysha Gene Therapies (TSHA|$1.3B) - 2025 Full Year Earnings Analysis
1 month ago
YouTubeSmartStockWatch
4:09
Trending in Gene and Cell Therapy: CAR-T Breakthrough Designation and more
16 views2 months ago
YouTubeLucidQuest
0:15
Taysha
5K views2 months ago
TikTok._.iriedescent..gyals._
3:30
Gene Therapy Basics
388K viewsJan 17, 2019
YouTubeASGCT
3:08
Hemophilia and Gene Therapy
48.2K viewsNov 11, 2019
YouTubeASGCT
1:31
Gene Therapy Inside Out
303.3K viewsDec 19, 2017
YouTubeU.S. Food and Drug Administration
3:21
Huntington's Disease: Can Gene Therapy Help?
29.1K viewsOct 15, 2019
YouTubeASGCT
1:20
What is Cell & Gene Therapy?
44.8K viewsFeb 26, 2020
YouTubeNovartis
5:12
New Gene Therapy Transforms SMA (Spinal Muscular Atrophy)
63.5K viewsJun 5, 2019
YouTubeUR Medicine
4:30
Gene Therapy and Sickle Cell Disease
59.2K viewsSep 17, 2020
YouTubeASGCT
See more